بدائل البحث:
significant cases » significant cause (توسيع البحث), significant based (توسيع البحث), significant changes (توسيع البحث)
greater decrease » greater increase (توسيع البحث), greater increases (توسيع البحث), rate decreased (توسيع البحث)
genes decrease » sizes decrease (توسيع البحث), teer decrease (توسيع البحث), greatest decrease (توسيع البحث)
cases based » case based (توسيع البحث), scores based (توسيع البحث), values based (توسيع البحث)
significant cases » significant cause (توسيع البحث), significant based (توسيع البحث), significant changes (توسيع البحث)
greater decrease » greater increase (توسيع البحث), greater increases (توسيع البحث), rate decreased (توسيع البحث)
genes decrease » sizes decrease (توسيع البحث), teer decrease (توسيع البحث), greatest decrease (توسيع البحث)
cases based » case based (توسيع البحث), scores based (توسيع البحث), values based (توسيع البحث)
-
141
-
142
-
143
-
144
-
145
-
146
-
147
-
148
Significantly Enriched Pathways.
منشور في 2025"…Pathway analysis revealed a marked decrease in expression within certain key metabolic pathways (such as the one-carbon pool by folate) in the NAFLD group, while expression in DNA repair-related pathways (such as non-homologous end joining) was significantly increased. …"
-
149
-
150
Defatting results in decreased gene expression of pro-inflammatory biomarkers.
منشور في 2020"…<p>Defatting of steatotic livers (DSL) results in significantly decreased gene expression of NF-κB and TNF-α compared to both the SL and LL groups. …"
-
151
-
152
-
153
-
154
Exercise is associated with a decrease in BMI.
منشور في 2022"…<p>There was a significant association between a greater number of exercise sessions attended and decreased BMI over the 6-month intervention period.…"
-
155
-
156
The base case analysis.
منشور في 2025"…</p><p>Results</p><p>In the base-case scenario, adding benmelstobart and anlotinib to chemotherapy increased QALYs by 0.34 at an additional cost of $24,684.07, yielding an ICER of $71,559.84 per QALY. …"
-
157
Base-case results.
منشور في 2025"…One-way and probabilistic sensitivity analyses were conducted to estimate the robustness of the model results,</p><p>Results</p><p>In base-case analysis, compared with toripalimab plus chemotherapy and chemotherapy alone, ITH-testing directed therapy could bring additional 0.14 QALYs and 0.29 QALYs, with marginal costs of $3750.75 and $7778.18, resulting in the ICER of $27,353.27/QALY and $26,461.46/QALY, respectively, which lower than the Chinese willingness-to-pay (WTP) threshold. …"
-
158
-
159
Base-case results.
منشور في 2024"…The model time-frame was one-year. Base-case analysis and sensitivity analysis were performed. …"
-
160
Base-case analysis.
منشور في 2023"…The willingness-to-pay (WTP) threshold was set at US$50,000 per QALY gained. In the base-case analysis, HTLV-1 antenatal screening (US$76.85, 24.94766 QALYs, 24.94813 LYs, ICER; US$40,100 per QALY gained) was cost-effective compared with no screening (US$2.18, 24.94580 QALYs, 24.94807 LYs). …"